APA

Arias-Pulido H., Cimino-Mathews A., Chaher N., Qualls C., Joste N., Colpaert C., Marotti J. D., Foisey M., Prossnitz E. R., Emens L. A. & Fiering S. (20190306). The combined presence of CD20 + B cells and PD-L1 + tumor-infiltrating lymphocytes in inflammatory breast cancer is prognostic of improved patient outcome. : Breast cancer research and treatment.

Chicago

Arias-Pulido H, Cimino-Mathews A, Chaher N, Qualls C, Joste N, Colpaert C, Marotti J D, Foisey M, Prossnitz E R, Emens L A and Fiering S. 20190306. The combined presence of CD20 + B cells and PD-L1 + tumor-infiltrating lymphocytes in inflammatory breast cancer is prognostic of improved patient outcome. : Breast cancer research and treatment.

Harvard

Arias-Pulido H., Cimino-Mathews A., Chaher N., Qualls C., Joste N., Colpaert C., Marotti J. D., Foisey M., Prossnitz E. R., Emens L. A. and Fiering S. (20190306). The combined presence of CD20 + B cells and PD-L1 + tumor-infiltrating lymphocytes in inflammatory breast cancer is prognostic of improved patient outcome. : Breast cancer research and treatment.

MLA

Arias-Pulido H, Cimino-Mathews A, Chaher N, Qualls C, Joste N, Colpaert C, Marotti J D, Foisey M, Prossnitz E R, Emens L A and Fiering S. The combined presence of CD20 + B cells and PD-L1 + tumor-infiltrating lymphocytes in inflammatory breast cancer is prognostic of improved patient outcome. : Breast cancer research and treatment. 20190306.